Insulin-like growth factor-binding proteins (IGFBPs) 
INTRODUCTION
The insulin-like growth factors (IGF-I and IGF-II) are 7-5 kDa peptides which stimulate cell proliferation and differentiation in a wide variety of tissues both antenatally and postnatally. Serum IGF-I and IGF-II levels in late pregnancy are elevated compared with those in non-pregnant subjects (Bala, Lopatka, Leung et al. 1981; Wilson, Bennet, Adamson et al. 1982; Wang & Chard, 1992) . In blood, the IGFs are associ¬ ated with binding proteins (IGFBPs) . The principle binding protein, designated IGFBP-3, carries the majority of endogenous IGF-I and IGF-II. The bind¬ ing complex has a molecular mass of 150 kDa and consists of an acid-stable IGF-binding subunit (53 kDa), an acid-labile non-IGF-binding subunit (100 kDa) and IGF-I and IGF-II (Baxter, 1988) . Another class of lower molecular mass binding pro¬ teins (25 kDa) are designated as IGFBP-1 and also bind both IGF-I and IGF-II (Brewer, Stetler, Squires et al. 1988) . IGFBP-1 is identical to placental protein 12 (PP12) purified from placenta and decidua (Bohn & Kraus, 1980; Julkunen, Koistinen, Aalto-Setala et al. 1988 ). IGFBP-2, a further small binding protein (30 kDa), is structurally and biologically distinct from IGFBP-1 and (Mottola, MacDonald, Backett et al. 1986; Brown, Chiariott, Orlowski et al. 1989 ) and binds IGF-II with a greater affinity than IGF-I. In man, IGFBP-2 is predominant in the cen¬ tral nervous system where IGF-II appears to be the main growth-promoting peptide (Hossenlopp, Seurin, Segovia-Quinson & Binoux, 1986; Rosenfeld, Pham, Conover et al. 1989 ).
Serum IGFBP-1 levels increase rapidly in the first trimester of pregnancy and reach a plateau from 12 weeks until term (Rutanen, Bohn & Seppala, 1982; Than, Csaba & Szabo, 1983; Wang, Perry, Kanisius et al. I99ìb) . The levels of IGFBP-3, as determined by radioimmunoassay (RIA) , are almost two-fold higher at term than those in non-pregnant women . However, recent studies using Western blotting have shown an apparent decrease of the acidstable IGF-binding subunits of IGFBP-3 in preg¬ nancy serum (Giudice, Farrell, Pham et al. 1990; Hossenlopp, Segovia, Lassarre et al. 1990 ). It has been suggested that IGFBP-3 is degraded by a pregnancyspecific protease as a result of increase of de-novo synthesis of this protease or a decrease of its inhibitor during pregnancy. This is further supported by the observation that the binding activity of IGFBP-3 in non-pregnant serum is also attenuated following incu¬ bation with term pregnancy serum at 37°C for 3-5 h (Giudice et al. 1990; Hossenlopp et al. 1990 ). This degradation of IGFBP-3 can be prevented by some, but not all, protease inhibitors (Davenport, Clemmons, Miles et al. 1990; Hossenlopp et al. 1990 ). Serum IGFBP-2 also decreases with the advance of gestation but to a lesser extent (Giudice et al. 1990 (Ciba-Geigy Ltd, Basel, Switzerland) , was iodinated using a modified chloramine procedure described previously (Wang, Lim, English et al. 1991 IGF-I to the serum samples during incubation (lanes 1, 3,5,7, and 9). In non-pregnant serum ( Fig. 2; lane4) , the major binding complex (cross-linked with 125I-labelled IGF-I) was at 41 kDa. This was progressively attenu¬ ated in pregnant serum ( Fig. 2; lanes 6 and 8) (Table 4c ). At 16 and 32 weeks gestation and term, the IGF-I cross-linking complex at 41 kDa was no longer seen whereas bands at 35 and 33 kDa appeared to be the major binding proteins in the 40 kDa fractions (Table 4c) .
IGFBPs in mixture ofnon-pregnant and pregnant serum Equal volumes of non-pregnant serum and serum from term delivery were incubated at 37°C for 0 h or 5 h followed by analysis on SDS-PAGE gels using cross-linking. (Wilkins & D'Ercole, 1985) ; 49 (most intense), 46, 40 and 37 kDa (Hardouin et al. 1987) and 47 kDa only (Gelato et al. 1990 (Peters & Richards, 1977 (Giudice et al. 1990; Hossenlopp et al. 1990 ). Similar protease activity is also said to degrade IGFBP-3 in serum from pregnant rats and mice (Davenport et al. 1990; Fielder, Thordarson, Talamantes & Rosenfeld, 1990 (Table Ab) . The varying subunit composition of the 150 kDa com¬ plexes may be due to specific proteases in pregnant serum. These smaller subunits still retain the ability to bind IGF-I, but with decreased affinity (Davies et al. 1991 (Lassarre, Hardouin, Daffos et al. 1986; Fielder et al. 1990 ). The paucity of 150 kDa binding proteins in fetal serum might reflect the immaturity of GH receptors on fetal cells since the 150 kDa IGFBPs are believed to be GH-dependent (Baxter, 1988) . 
